BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2026 6:11:14 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-03-12 00:35 |
|
Peer-Review Started |
|
2026-03-12 00:35 |
|
First Decision by Editorial Office Director |
|
2026-03-20 10:50 |
|
Return for Revision |
|
2026-03-20 10:50 |
|
Revised |
|
2026-03-23 12:55 |
|
Publication Fee Transferred |
|
2026-04-19 10:07 |
|
Second Decision by Editor |
|
2026-04-16 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-16 06:26 |
|
Articles in Press |
|
2026-04-16 06:26 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-06 02:46 |
|
Publish the Manuscript Online |
|
2026-07-24 06:11 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer, leapfrogging oncomatrix biomarkers for high-risk patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ilya Klabukov, Denis Baranovskii, Daria Eygel and Elena Yatsenko |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Russian Science Foundation |
24-64-00028 |
|
| Corresponding Author |
Ilya Klabukov, Associate Professor, Head, PhD, Department of Regenerative Medicine, National Medical Research Radiological Center, 4 Koroleva Street, Obninsk 249036, Kaluzhskaya Oblast’, Russia. ilya.klabukov@gmail.com |
| Key Words |
Breast cancer; Cancer; Cancer stem cells; Cell regulation; Epithelial-mesenchymal transition; Extracellular matrix; Leapfrogging; Personalized medicine; Triple-negative breast cancer; Tumor |
| Core Tip |
Advanced diagnostics are required not as replacements for existing approaches, but for application in developing economies that lack the resources to support high-cost diagnostic techniques. The use of advanced substitutional biomarkers associated with cancer stem cells or tumor extracellular matrix properties could enable leapfrogging toward personalized therapy. |
| Publish Date |
2026-07-24 06:11 |
| Citation |
Klabukov I, Baranovskii D, Eygel D, Yatsenko E. Letter to the Editor: Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer, leapfrogging oncomatrix biomarkers for high-risk patients. World J Clin Oncol 2026; 17(7): 120955
|
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i7/120955.htm |
| DOI |
https://doi.org/10.5306/wjco.120955 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
